InvestorsHub Logo
Followers 17
Posts 943
Boards Moderated 0
Alias Born 08/24/2020

Re: medicinecat post# 23843

Wednesday, 02/10/2021 12:55:28 PM

Wednesday, February 10, 2021 12:55:28 PM

Post# of 36642
I appreciate that Medicine. I got land blasted in December and put on “ ignore “ by a few here when I told people that initial data was never coming.

I know many on this board play the OTC like it’s Fantasy Football (or hockey for our Canadian friends), watching it minute by minute. I admit, I’ve got enough shares that I loose or gain a lot of money with each penny movement. But, I’m calm. Why?

Maybe I have a better handle on my emotions, or I don’t have attention deficit disorder, or maybe it’s because:-
- Pharm Olam has a wonderful reputation on trial study performance.
- Prior to the trial, Dr. Kelly McKee was enthusiastic about the Bucillamine hypothesis with regards to Covid.
- The trial itself is considered a Gold Standard, and any data released before all the data is in, would actually be bad news.
- There are indications of positive trial results, with out the data.
1) Frank’s comments in PR prior to Christmas
2) Adding sites in January
3) Funding from large investors, which sets the new floor in share price until news does break.
4) Hiring Research Doctor, in Fahy, that has overseen a Thiol Donor study.

I’ve always said trust the science, and the UCSF study was more encouraging than I had ever hoped for.

Good news is coming and the market is larger than just North America.